Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

This track includes  Pharmaceutical : Pre-Formulation and Formulation aspects which  is the process in which different chemical substances i.e., active chemical substances will combined together to produce a medical compound i.e., medical drug. This process involves production of drug which characterized by two things: Stability of the product, second Acceptability to the patient. Formulation studies focuses on factors like particle size, polymorphism, pH and solubility, in order to check whether these factors will effect on bioavailability of the drug or not. Pharmaceutical Formulations include Ophthalmic Formulation, Paediatric Formulation Development, Topical Formulation and Medication Formulation.

This track is representing Pharmaceutical Excipients Pharmaceutical Product Development ,Types of Drug Formulation ,Ophthalmic Formulation ,Pediatric Formulation Development, Medication Formulation ,Topical Formulations

Pharmaceutical Formulations Market Size worth $ 8.24 Billion By 2021 | CAGR: 6.8%

The global Pharmaceutical Formulations market is estimated to reach USD 8.24 Billion by 2021, growing at a CAGR of 6.8% during the forecast period

 

  • Track 1-1 Preformulation in Drug Discovery
  • Track 1-2 Preformulation in Drug Development
  • Track 1-3 Drug Formulation Considerations
  • Track 1-4 Major Challenges in Drug Development
  • Track 1-5 Physiological Drug Environment
  • Track 1-6 Freeze Drying
  • Track 1-7 Hot Melt Extrusion

This track will include the usage of Pharmacokinetics and Pharmacodynamics in Drugs. Pharmacology is basically  the study of drugs. Pharmacodynamics is the effect that drugs have on the body. Pharmacokinetics is the effect the body has on the drugs. Pharmacokinetics includes absorption, distribution, metabolism and excretion of drugs.

Few major topics of this session will be: Pharmacokinetic Parameters, Pharmacodynamic Parameters, Absorption of Drugs, Distribution of Drugs, Biotransformation/Metabolism, Excretion of Drugs, Pharmacodynamics

 

  • Track 2-1 Pharmacokinetic Parameters
  • Track 2-2 Pharmacodynamic Parameters
  • Track 2-3 Absorption of Drugs
  • Track 2-4 Distribution of Drugs
  • Track 2-5 Biotransformation/Metabolism
  • Track 2-6 Excretion of Drugs
  • Track 2-7 Pharmacodynamics

In this session we will talk about the main objective in drug design and drug targeting. Drug design is to foresee whether a given particle will bind to a target and if so how unequivocally. Molecular mechanics or molecular dynamics are regularly used to predict the conformation of the little particle and to model conformational changes in the biological targets that may happen when the little molecules ties to it. The remedial reaction of a drug relies on the cooperation of drug molecules with cell on cell membrane related biological events at receptor sites in concentration dependent manner.

Few major tracks of this session will be: Drug Targeting strategies, Factors influencing Drug Targeting, Advances in Drug Targeting components, Recent Approaches to Drug Targeting, Rational Drug Design, Computer Aided Drug Design

 

  • Track 3-1 Drug Targeting strategies
  • Track 3-2 Factors influencing Drug Targeting
  • Track 3-3 Advances in Drug Targeting components
  • Track 3-4 Recent Approaches to Drug Targeting
  • Track 3-5 Rational Drug Design
  • Track 3-6 Computer Aided Drug Design

In this session we will talk about the route of administration in pharmacology and toxicology which is basically the path by which a drug, fluid, poison, or other substance is taken into the body. Routes of administration are generally classified by the location at which the substance is applied.

Few major tracks of this session will be: Oral Drug Delivery, Buccal Drug Delivery, Nasal Drug Delivery,  Ophthalmic Drug Delivery, Topical Drug Delivery, Pulmonary Drug Delivery, Parenteral Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Geriatric Drug Delivery, Pediatric Drug Delivery

 

  • Track 4-1 Oral Drug Delivery
  • Track 4-2 Buccal Drug Delivery
  • Track 4-3 Nasal Drug Delivery
  • Track 4-4 Ophthalmic Drug Delivery
  • Track 4-5 Topical Drug Delivery
  • Track 4-6 Pulmonary Drug Delivery
  • Track 4-7 Parenteral Drug Delivery
  • Track 4-8 Rectal Drug Delivery
  • Track 4-9 Vaginal Drug Delivery
  • Track 4-10Geriatric Drug Delivery
  • Track 4-11Paediatric Drug Delivery

 

This track will includes  Nanoparticle technology which recently showed to hold a great promise for drug delivery applications in nanomedicine due to its beneficial properties, such as better encapsulation, bioavailability, control release, and lower toxic effect. Despite the great progress in nanomedicine, there remain many limitations for clinical applications on nanocarriers. Synthesizing nanoparticles for pharmaceutical purposes such as drug preparation can be done in two methods. Bottom up process such as pyrolysis, inert gas condensation, solvothermal reaction, sol-gel fabrication and structured media in which hydrophobic compound such as liposomes are used as bases to mount the drug. Top down process such as attrition / milling in which the drug is chiseled down to form a nanoparticle.To overcome these limitations, advanced nanoparticles for drug delivery have been developed to enable the spatially and temporally controlled release of drugs in response to specific stimuli at disease sites. Furthermore, the controlled self-assembly of organic and inorganic materials may enable their use in theranostic applications. This review presents an overview of a recent advanced nanoparticulate system that can be used as a potential drug delivery carrier and focuses on the potential applications of nanoparticles in various biomedical fields for human health care. A novel process for synthesis of polymeric nanoparticles for use in drug delivery applicationsusing the electrospraying technique. The technologyis standardized for synthesis of natural polymer based nanoparticles such as chitosan-gelatin based nanoparticles.

 

  • Track 5-1Liposomal Drug Delivery Systems
  • Track 5-2Microemulsions and Nanoemulsions
  • Track 5-3Solid Lipid Nano and Microparticles
  • Track 5-4Organic Nanotubes: Promising Vehicles for Drug Delivery
  • Track 5-5Dendrimers
  • Track 5-6Micelles
  • Track 5-7Cyclodextrins
  • Track 5-8Polymers
  • Track 5-9Nanogels
  • Track 5-10Metal Nanoparticles and Quantum Dots

Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. Using nanoparticle contrast agents, images such as ultrasound and MRI have a favorable distribution and improved contrast. This might be accomplished by self assembled biocompatible nanodevices that will detect, evaluate, treat and report to the clinical doctor automatically. Nanotechnology ("nanotech") is manipulation of matter on an atomic, molecular, and supramolecular scale. The earliest, widespread description of nanotechnology referred to the particular technological goal of precisely manipulating atoms and molecules for fabrication of macro scale products, also now referred to as molecular nanotechnology. A more generalized description of nanotechnology was subsequently established by the National Nanotechnology Initiative, which defines nanotechnology as the manipulation of matter with at least one dimension sized from 1 to 100 nanometers.

 

  • Track 6-1Cosmetics
  • Track 6-2Controlled Drug Delivery
  • Track 6-3Transdermal Drug Delivery
  • Track 6-4Dermal Drug Delivery
  • Track 6-5Antimicrobial nanoemulsions
  • Track 6-6Cancer therapy
  • Track 6-7Treatment of other diseases
  • Track 6-8Oral delivery of poorly soluble drugs

Nano pharmaceuticals offer the ability to detect diseases at much earlier stages and the diagnostic applications could build upon conventional procedures using nanoparticles. Nano pharmaceuticals represent an emerging field where the sizes of the drug particle or a therapeutic delivery system work at the Nano scale. In the pharmaceutical industry, a long standing issue is the difficulty of delivering the appropriate dose of a particular active agent to specific disease site. Nano pharmaceuticals have enormous potential in addressing this failure of traditional therapeutics which offers site-specific targeting of active agents. Such precision targeting via Nano pharmaceuticals reduces toxic systemic side effects, resulting in better patient compliance. In today world economy, a pharmaceutical industry faces enormous pressure to deliver high-quality products to patients while maintaining profitability. Therefore pharmaceutical companies are applying nanotechnology to enhance or supplement drug target discovery and drug delivery. Nano pharmaceutical reduces the cost of drug discovery, design & development and enhances the drug delivery process.

 

  • Track 7-1Pharmaceutical Nanotechnology based Systems
  • Track 7-2Characterization of Pharmaceutical Nanotools
  • Track 7-3Engineering of Pharmaceutical Nanosystems
  • Track 7-4Applications of Pharmaceutical Nanotools
  • Track 7-5Challenges to Pharmaceutical Nanotechnology
  • Track 7-6Future Prospects of Pharmaceutical Nanotechnology

With Smart Drug Delivery Technology the unprecedented progresses of biomedical nanotechnology during the past few decades, conventional drug delivery systems (DDSs) have been involved into smart DDSs with stimuli-responsive characteristics. To enhance their therapeutic effects and reduce the related side effects, active drug molecules should selectively accumulate in the disease area for a prolonged period with high controllability. Drug delivery refers to the approaches, formulations, technologies, and systems for transporting therapeutics in the body as needed to safely and efficiently achieve their desired therapeutic effects. Conventional drug delivery systems  (DDSs) are often accompanied by systemic side effects that mainly attributable to their nonspecific bio-distribution and uncontrollable drug release characteristics. To overcome these limitations, advanced controlled DDSs have been developed to achieve the release of payloads at the target sites in a spatial controlled manner. In comparison to the conventional DDSs, the smart controlled DDSs can effectively reduce the dosage frequency, while maintaining the drug concentration in targeted organs/tissues for a longer period of time. In this sense, the controlled DDSs provide broad insights and fascinating properties for decreasing drug concentration fluctuation, reducing drug toxicities and improving therapeutic efficacy.

 

  • Track 8-1Targeted Drug Delivery
  • Track 8-2Brain Delivery
  • Track 8-3Mucosal Drug Delivery
  • Track 8-4Skin Drug Delivery
  • Track 8-5Pulmonary Drug Delivery
  • Track 8-6Cancer Delivery
  • Track 8-7Insulin Delivery
  • Track 8-8Self-Emulsifying Drug Delivery Systems (SEDDS)
  • Track 8-92D and 3D Printing In Drug Delivery
  • Track 8-10BioMEMS
  • Track 8-11Blood Brain Barrier Delivery
  • Track 8-12Antibody Targeted-Drug Conjugates
  • Track 8-13Nucleic Acid Drug Delivery Systems
  • Track 8-14Gene Delivery

This track will includes  Nanoparticle technology which recently showed to hold a great promise for drug delivery applications in nanomedicine due to its beneficial properties, such as better encapsulation, bioavailability, control release, and lower toxic effect. Despite the great progress in nanomedicine, there remain many limitations for clinical applications on nanocarriers. Synthesizing nanoparticles for pharmaceutical purposes such as drug preparation can be done in two methods. Bottom up process such as pyrolysis, inert gas condensation, solvothermal reaction, sol-gel fabrication and structured media in which hydrophobic compound such as liposomes are used as bases to mount the drug. Top down process such as attrition / milling in which the drug is chiseled down to form a nanoparticle.To overcome these limitations, advanced nanoparticles for drug delivery have been developed to enable the spatially and temporally controlled release of drugs in response to specific stimuli at disease sites. Furthermore, the controlled self-assembly of organic and inorganic materials may enable their use in theranostic applications. This review presents an overview of a recent advanced nanoparticulate system that can be used as a potential drug delivery carrier and focuses on the potential applications of nanoparticles in various biomedical fields for human health care. A novel process for synthesis of polymeric nanoparticles for use in drug delivery applicationsusing the electrospraying technique. The technologyis standardized for synthesis of natural polymer based nanoparticles such as chitosan-gelatin based nanoparticles.

 

  • Track 9-1Cells and Proteins
  • Track 9-2Proteins and Surfaces
  • Track 9-3Ceramics and Metals
  • Track 9-4Polymers
  • Track 9-5Wound Healing
  • Track 9-6Translational Sciences
  • Track 9-7Biomaterials Processing & Devices
  • Track 9-83D Printing Technologies
  • Track 9-9Biomaterials & Therapeutics
  • Track 9-10Musculoskeletal
  • Track 9-11Nanomaterials & Nanotechnologies
  • Track 9-12Tissue Regeneration

Vaccine is a material that induces an immunologically mediated resistance to a disease but not necessarily an infection. Vaccines are generally composed of killed or attenuated organisms or subunits of organisms or DNA encoding antigenic proteins of pathogens. Sub-unit vaccines though exceptionally selective and specific in reacting with antibodies often fail to show such reactions in circumstances such as shifts in epitopic identification center of antibody and are poorly immunogenic. Delivery of antigens from oil-based adjuvants such as Freunds adjuvant lead to a reduction in the number of doses of vaccine to be administered but due to toxicity concerns like inductions of granulomas at the injection site, such adjuvants are not widely used. FDA approved adjuvants for human uses are aluminium hydroxide and aluminium phosphate in the form of alum. Hence, search for safer and potent adjuvants resulted in the formulations of antigen into delivery systems that administer antigen in particulate form rather than solution form.

  • Track 10-1Cancer vaccines
  • Track 10-2Influenza vaccines/virus
  • Track 10-3Novel vaccines
  • Track 10-4Clinical trials
  • Track 10-5Human vaccines
  • Track 10-6HIV/AIDS vaccines
  • Track 10-7HPV vaccines
  • Track 10-8Therapeutic vaccination for auto immune diseases
  • Track 10-9New vaccines
  • Track 10-10Veterinary vaccines
  • Track 10-11Computed Tomographic Scanning (CT Scanning)
  • Track 10-12Magnetic Resonance Imaging

  • Track 11-1Biomedical Instrumentation Measurements
  • Track 11-2Measurement of Blood Flow and Cardiac Output
  • Track 11-3Instrumentation for Psychophysiological Measurements
  • Track 11-4Instrumentation for the Experimental Analysis of Behaviour
  • Track 11-5Respiratory Therapy Equipment
  • Track 11-6Pacemakers and Defibrillators
  • Track 11-7Quality by Design (QbD)
  • Track 11-8Instrumentation for the Medical Use of Radioisotopes
  • Track 11-9Ophthalmic and ENT Instruments
  • Track 11-10Ultrasonography
  • Track 11-11Positron-Emission Tomographic (PET) Scanning

  • Track 12-1Peptide Vector for Biologics Brain Delivery
  • Track 12-2Protein Formulation & Aggregation
  • Track 12-3Protein therapeutics
  • Track 12-4Polymers for delivery of proteins
  • Track 12-5Peptide therapeutics
  • Track 12-6Peptide therapeutics
  • Track 12-7Cell-penetrating and cell-targeting